MedTrace Logo

FMT Capsules for rCDI

NCT07458984 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-04-29

No results posted yet for this study

Summary

Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.

Conditions

  • Clostridioides Difficile Infection Recurrence
  • FMT

Interventions

BIOLOGICAL

Healthy donor stool

Healthy donor stool given by capsules produced by the same method as in Copenhagen University Hospital

BIOLOGICAL

placebo capsule

Copenhagen University Hvidrovre Hospital method for capsule production

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Perttu Arkkila, Professor · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-25
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07458984 on ClinicalTrials.gov